It’s known that combination therapies can be used to create ideal treatment outcomes, but according to Dr. Suneel Chilukuri, results may also last longer than originally thought.
Millennials think of aesthetic treatments no differently than other beauty appointments, according to Dr. Ava Shamban. These are their top facial concerns.
In a skit depicting Carnac the Magnificent, Drs. Rosen and Bhatia presented on 2020's new drugs and technologies at the current Maui Derm for Dermatologists, all with a magical twist.
In his presentation at the current Maui Derm 2020, Dr. Curtis Cole tackled the controversy of how SPF labeling can differ significantly from the actual protection.
An analysis by Vanguard Communications suggests more weight is attached to physician patient reviews compared to those of hotels and restaurants.
With advancements in deep next-generation sequencing (NGS) and bioinformatics analysis, the authors of a recent study suggest the skin microbiome may hold promise as a clinical biomarker in atopic dermatitis (AD) management.
A recent study reports findings that support dupilumab as a safe, long-term treatment in patients with moderate-to-severe atopic dermatitis.
Recent phase 3 clinical trials reveal positive results for tazarotene lotion 0.045% in patients with moderate-to-severe acne.
Off-label product use is fairly common in aesthetics and plays a key role in advancing treatment practices in the specialty. Dr. Amy Foreman Taub explains the four she uses on a regular basis.
The distribution agreement between Revance and Swiss HA-based dermal filler and cosmeceutical manufacturing company, TEOXANE SA, may position Revance as a leader in the U.S. facial injectable market.